Showing 7321-7330 of 20894 results for "".
- Ensuring ‘Pediatric Readiness’ in Emergency Departments Costs Little and Saves Liveshttps://reachmd.com/news/ensuring-pediatric-readiness-in-emergency-departments-costs-little-and-saves-lives/2467075/AUSTIN, Texas — The price tag for making hospital emergency departments ready to provide basic care to children is minimal — ranging from just $4 to $48 per patient — while significantly improving survival rates, according to a
- Risk Factors for Long COVID Revealedhttps://reachmd.com/news/risk-factors-for-long-covid-revealed/2467077/NEW YORK, NY (June 14, 2024)--Early in the pandemic, many people who had SARS-Cov-2 infection or COVID-19 began to report that they couldn’t shake off their symptoms even after a month or more—unusually long for a viral infection of the upper re
- Evaxion’s AI-Powered Cancer Vaccine Demonstrates High Response in Early Studyhttps://reachmd.com/news/evaxions-ai-powered-cancer-vaccine-demonstrates-high-efficacy-in-early-study/2467073/Evaxion Biotech A/S, a firm specializing in AI-driven immunology vaccines, recently published data from its Phase 1 dose escalation study of the EVX-01 personalized cancer vaccine for metastatic melanoma showing almost 70% clinical response from patients. The study, published in the J
- Study: Advanced AI Enhances Melanoma Detectionhttps://reachmd.com/news/study-advanced-ai-enhances-melanoma-detection/2467071/A new study suggests a novel deep-learning model based on diagnostic data may help harness the power of neural networks and artificial intelligence (AI) to more accurately diagnose melanoma.
- Prenatal Supplements Fall Woefully Short in Providing Crucial Nutrition During Pregnancyhttps://reachmd.com/news/prenatal-supplements-fall-woefully-short-in-providing-crucial-nutrition-during-pregnancy/2467053/If there’s one thing doctors agree on, it’s that all of their pregnant patients should take prenatal supplements. As a result, about 3 in 4 expecting mothers follow their doctor’s advice. But even though th
- Trametinib Shows Promise for Children with Relapsed or Refractory Juvenile Myelomonocytic Leukemiahttps://reachmd.com/news/trametinib-shows-promise-for-children-with-relapsed-or-refractory-juvenile-myelomonocytic-leukemia/2467049/Credit: Pixabay/CC0 Public Domain The MEK inhibitor trametinib (Mekinist) was an effective treatment for pediatric pa
- FDA Approves New Tralokinumab-ldrm Autoinjectorhttps://reachmd.com/news/fda-approves-new-tralokinumab-ldrm-autoinjector/2467047/The US Food and Drug Administration (FDA) announced the approval of a new tralokinumab-ldrm 300-mg single-dose autoinjector for adult patients. Adbry® (LEO Pharma Inc.), a high-affinity fully human monoclonal antibody, is currently indicated in the US for the treatment of moderate-to-sever
- Ruxolitinib cream 1.5% Demonstrates Tolerability, Safety Over 52 Weeks in Childrenhttps://reachmd.com/news/ruxolitinib-cream-15-demonstrates-tolerability-safety-over-52-weeks-children/2467044/Ruxolitinib cream 1.5% demonstrated consistently good tolerability and safety over 52 weeks in children 2 to 11 years old with extensive moderate-to-severe atopic dermatitis (AD) in a study presented this month at the Revolutionizing Atopic Dermatitis (RAD) Conference in Chicago, Illinois.
- Moderate-to-Severe AA Linked to AD Comorbidityhttps://reachmd.com/news/moderate-severe-aa-linked-ad-comorbidity/2467042/Patients with moderate-to-severe alopecia areata (AA) had higher prevalence and incidence of atopic dermatitis (AD) comorbidity and higher prevalence of moderate-to-severe AD than those with mild AA in a study presented this month at the Revolutionizing Alopecia, Vitligo, and Eczema (RAVE) Confer
- Suntegrity Recalls Multiple Lots of Sunscreen Foundationhttps://reachmd.com/news/suntegrity-recalls-multiple-lots-sunscreen-foundation/2467041/Suntegrity Skincare has announced that it is recalling nine lots of Suntegrity Impeccable Skin Sunscreen Foundation (Multiple Shades) due to the discovery of a higher-than-acceptable microbiological mold count (Aspergillus sydowii), according to an FDA alert. According to the man